ABBREVIATIONS


ABC

abacavir

ACTG

AIDS Clinical Trials Group

AIDS

acquired immunodeficiency syndrome

ALT

alanine aminotransferase

ART

antiretroviral therapy

ARV

antiretroviral

ATV

atazanavir


bid

twice daily


CD4

T-lymphocyte CD4+

CNS

central nervous system


d4T

stavudine

DART

development of antiretroviral therapy in Africa

ddI

didanosine

DOT

directly observed therapy


EFV

efavirenz

ENF (T-20)

enfuvirtide


FBC

full blood count

FDC

fixed-dose combination

FTC

emtricitabine


GI

gastrointestinal


HAART

highly active antiretroviral therapy

Hgb

haemoglobin

HIV

human immunodeficiency virus

HIVab

human immunodeficiency virus antibody


IDU

injecting drug user

IDV

indinavir


LPV

lopinavir


MTCT

mother-to-child transmission (of HIV)


NAM

nucleoside analogue mutation

NFV

nelfinavir

NGO

nongovernmental organization

NNRTI

non-nucleoside reverse transcriptase inhibitor

NsRTI

nucleoside analogue reverse transcriptase inhibitor

NtRTI

nucleotide analogue reverse transcriptase inhibitor

NVP

nevirapine


PCR

polymerase chain reaction

PI

protease inhibitor


qd

once daily


RT

reverse transcriptase

RTI

reverse transcriptase inhibitor

RTV

ritonavir



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement